About Sahlgrenska Sjukhuset; Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Sahlgrenska Sjukhuset; Neurology
During the past decade, Sahlgrenska Sjukhuset; Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
2018-07-12
2025-08-26
Recruiting
1,500
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sahlgrenska Sjukhuset; Neurology
According to Clinical.Site data, the most researched conditions in "Sahlgrenska Sjukhuset; Neurology" are
"Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Multiple Sclerosis" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Sahlgrenska Sjukhuset; Neurology" in a lesser frequency.
Clinical Trials Intervention Types at Sahlgrenska Sjukhuset; Neurology
Most popular intervention types in "Sahlgrenska Sjukhuset; Neurology" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (4 trials), "Interferon beta-1a" (1 trials), "Interferon beta-1a-matching placebo" (1 trials) and "Ocrelizumab-matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sahlgrenska Sjukhuset; Neurology
The vast majority of trials in "Sahlgrenska Sjukhuset; Neurology" are
4 trials for "All" genders.
Clinical Trials Status at Sahlgrenska Sjukhuset; Neurology
Currently, there are NaN active trials in "Sahlgrenska Sjukhuset; Neurology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Sahlgrenska Sjukhuset; Neurology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sahlgrenska Sjukhuset; Neurology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".